Related Experiment Videos
Delayed molecular responses to brain irradiation
C S Chiang1, J H Hong, A Stalder
1Department of Nuclear Science, Tsing-Hua University, Hsing-Chu, Taiwan.
International Journal of Radiation Biology
|July 1, 1997
Summary
Late brain damage after cancer irradiation is a major concern. This study in mice suggests tumor necrosis factor-alpha (TNF-alpha) may play a role in these delayed neurological complications.
Area of Science:
- Neuroscience
- Oncology
- Radiology
Background:
- Late-onset complications following brain irradiation impede cancer therapy efficacy.
- The molecular mechanisms underlying radiation-induced brain damage remain largely unknown.
- Identifying these mechanisms is crucial for developing therapeutic interventions.
Purpose of the Study:
- To investigate the expression of key molecules implicated in brain damage following irradiation.
- To delineate the temporal molecular and cellular events contributing to late radiation effects in the brain.
Main Methods:
- Gene expression analysis of cytokines, cytokine receptors, cell adhesion molecules, iNOS, anti-chymotrypsin, and GFAP in a murine model.
- Utilized a sensitive RNase protection assay (RPA) over a 6-month period post-irradiation.
- Compared acute (24h) and late (2-6 months) molecular responses.
Main Results:
- Confirmed acute, transient responses of TNF-alpha, IL-1, ICAM-1, EB22/5.3, and GFAP within 24 hours.
- Observed re-elevation of TNF-alpha, EB22/5.3, and GFAP mRNA at 2-3 months.
- Found sustained overexpression of TNF-alpha mRNA at 6 months, coinciding with observed neurological abnormalities.
Conclusions:
- Data suggest a potential role for tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of late brain responses to irradiation.
- TNF-alpha may contribute to the clinical symptoms of radiation-induced brain damage.
- Further research into TNF-alpha as a therapeutic target is warranted.